HLA DQ/DR/DP Antibody (WR18) - BSA Free | Novus Biologicals NB100-64358 product information

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

HLA DQ/DR/DP Antibody (WR18) - BSA Free

catalog :

NB100-64358

quantity :

0.1 mg (also 0.025 mg, 0.2 mg)

price :

409 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

WR18

reactivity :

human

application :

immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section

more info or order :

Novus Biologicals product webpage

citations: 5

Reference
O Connell B, Hubbard C, Zizlsperger N, Fitzgerald D, Kutok J, Varner J, et al. Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenviron. J Immunother Cancer. 2024;12: pubmed publisher
Kendall T, Jimenez Ramos M, Turner F, Ramachandran P, Minnier J, McColgan M, et al. An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nat Med. 2023;29:2939-2953 pubmed publisher
Hartman K, Steiner G, Siegel M, Looney C, Hickling T, Bray French K, et al. Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes. Biology (Basel). 2023;12: pubmed publisher
Liu Y, Yang J, Hilliard T, Wang Z, Johnson J, Wang W, et al. Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy. J Exp Clin Cancer Res. 2023;42:165 pubmed publisher
Bockorny B, Semenisty V, Macarulla T, Borazanci E, Wolpin B, Stemmer S, et al. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial. Nat Med. 2020;26:878-885 pubmed publisher

image

image 1 :

Flow Cytometry: HLA DQ/DR/DP Antibody (WR18) - BSA Free [NB100-64358]

product information

master code :

NB100-64358

SKU :

NB100-64358

product name :

HLA DQ/DR/DP Antibody (WR18) - BSA Free

unit size :

0.1 mg (also 0.025 mg, 0.2 mg)

description :

The HLA DQ/DR/DP Antibody (WR18) - BSA Free from Novus is a mouse monoclonal antibody to HLA DQ/DR/DP. This antibody reacts with human. The HLA DQ/DR/DP Antibody (WR18) - BSA Free has been validated for the following applications: Immunoprecipitation,Immunocytochemistry/ Immunofluorescence,Functional,Immunohistochemistry-Paraffin,Flow Cytometry,Immunohistochemistry.

target :

HLA DQ/DR/DP

category :

Primary Antibodies

buffer :

PBS

clonality :

Monoclonal

clone :

WR18

concentration :

1.0 mg/ml

conjugate :

Unconjugated

host :

Mouse

immunogen :

Human HLA Class II (DP, DQ, DR)

isotype :

IgG2a

purity :

Protein G purified

species :

Human

specificity :

Recognizes HLA Class II beta chains of human major histocompatability antigen, Mw 28 kD

gene symbol :

HLA-DQA1

applications :

Immunoprecipitation,Immunocytochemistry/ Immunofluorescence,Functional,Immunohistochemistry-Paraffin,Flow Cytometry,Immunohistochemistry

USD :

409 USD

alt names :

CD, CELIAC1DQ alpha 1 chain, DC-1 alpha chain, DQ-A1, FLJ27088, FLJ27328, GSE, HLA class II histocompatibility antigen, DQ(W3) alpha chain, HLA-DCA, HLA-DQA, leucocyte antigen DQA1, leukocyte antigen alpha chain, major histocompatibility complex, class II, DQ alpha 1, MGC149527, MHC class II antigen, MHC class II DQA1, MHC class II HLA-D alpha glycoprotein, MHC class II HLA-DQ-alpha-1, MHC class II surface glycoprotein, MHC HLA-DQ alpha

storage :

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

more info or order :

Novus Biologicals product webpage